Effect of glucose on production and release of proinsulin conversion products by cultured human islets

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 4, 1998, Pages 1234-1238

  Zambre, Yasmeeni ^c   Ling, Zhidong ^c   Hou, Xue ^c   Foriers, Andre ^c   Van Den Bogaert, Bas ^a   Van Schravendijk, Chris ^c   Pipeleers, Daniel ^b  

^a DIABETES RESEARCH CENTER   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; PROINSULIN;

ADULT; ANIMAL CELL; ARTICLE; FEMALE; GLUCOSE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; MALE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; GLUCOSE; HUMANS; ISLETS OF LANGERHANS; PROINSULIN; RATS;

ANIMALIA;

EID: 0031763798     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.4.1234     Document Type: Article

References (28)

1. Davidson HW, Hutton JC. 1987 The insulin-secretory-granule carboxypeptidase H. Purification and demonstration of involvement in proinsulin processing. Biochem J. 245:575-582.
2. Bailyes EM, Shennan KIJ, Seal AJ, et al. 1992 A member of the eukaryoric subtilisin family (PC3) has the enzymatic properties of the type 1 proinsulin-converting endopeptidase. Biochem J. 285:391-394.
3. Bennett DL, Bailyes EM, Nielsen E, et al. 1992 Identification of the type 2 proinsulin processing endopeptidase as PC2, a member of the eukaryote subtilisin family. J Biol Chem. 267:15229-15236.
4. Sizonenko S, Irminger J-C, Buhler L, Deng S, Morel P, Halban PA. 1993 Kinetics of proinsulin conversion in human islets. Diabetes. 42:933-936.
5. Sizonenko SV, Halban PA. 1991 Differential rates of conversion of rat proinsulins I and II. Evidence for slow cleavage at the B-chain/C-peptide junction of proinsulin II. Biochem J. 278:621-625.
6. Vollenweider F, Irminger J-C, Halban PA. 1993 Substrate specificity of proinsulin conversion in the constitutive pathway of transfected FAO (hepatoma) cells. Diabetologia. 36:1322-1325.
7. Irminger JC, Vollenweider FM, Neerman-Arbez M, Halban PA. 1994 Human proinsuin conversion in the regulated and the constitutive pathways of transfected At20 cells. J Biol Chem. 269:1756-1762.
8. Neerman-Arbez M, Sizonenko SV, Halban PA. 1993 Slow cleavage at the proinsulin B-chain/connecting pepride junction associated with low levels of endoprotease PC1/3 in transformed β cells. J Biol Chem. 268:16098-16100.
9. Vollenweider F, Irminger J-C, Gross DJ, Komaroff LV, Halban PA. 1991 Processing of proinsulin by transfected hepatoma (FAO) cells. J Biol Chem. 267:14629-14636.
10. Smeekens SP, Montag AG, Thomas G. 1992 Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc Natl Acad Sci USA. 89:8822-8826.
11. Naggert JK, Fricker LD, Varlamov O, et al. 1995 Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet. 10:135-142.
12. Rhodes CJ, Alarcònn C. 1994 What β-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes. 43:511-517.
13. Schuppin GT, Rhodes CJ. 1996 Specific co-ordinated regulation of PC3 and PC2 gene expression with that of preproinsulin in insulin-producing β TC3 cells. Biochem J. 313:259-268.
14. Pipeleers D. 1994 Treatment of diabetes by islet cell transplantation. In: Baya C, ed. Biomedical and health research. Advances in Medical Biology. IOS Press Amsterdam: vol 3:185-197.
15. Ling Z, Pipeleers D. 1996 Prolonged exposure of human β cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest. 98:2805-2812.
16. Pipeleers DG, In't Veld PA, Van De Winkel M, Maes E, Scuit FC, Gepts W. 1985 A new in vitro model for the study of pancreatic A and B cells. Endocrinology. 117:806-816.
17. Ling Z, Pipeleers D. 1994 Preservation of glucose-responsive islet β-cells during serum-free culture. Endocrinology. 134:2614-2621.
18. Linde S, Welinder BS, Nielsen JH. 1993 Analysis of proinsulin and its conversion products by reversed-phase high-performance liquid chromatography. J Chromatogr. 614:185-204.
19. Sodoyez JC, Koch M, Lemoir I, et al. 1991 Influence of affinity of antibodies upon their detection by liquid phase radiobinding assay and solid phase enzyme linked immunosorbent assay. Demonstration using monoclonal antibodies raised against rDNA human proinsulin. Diabetologia. 34:463-468.
20. Hou X, Ling Z, Zambre Y, et al. 1997 Proinsulin and its conversion intermediates in human pancreas and isolated islet tissue: kinetics and steady state analysis. Pancreas. 15:113-121.
21. Scheeren PJH, Barna P, Smit H. 1985 A software package for the evaluation of peak parameters in an analytical signal based on a non-linear regression method. Anal Chim Acta. 167:65-80.
22. Martin SK, Carroll R, Benig M, Steiner DF. 1994 Regulation by glucose of the biosynthesis of PC2, PC3 and proinsulin in (ob/ob) mouse islets of Langerhans. FEBS Lett 356:279-282.
23. Skelly RH, Schuppin GT, Ishihara H, Oka Y, Rhodes CJ. 1996 Glucose-regulated translational control of proinsulin biosynthesis with that of the proinsulin endopeptidases PC2 and PC3 in the insulin producing MIN6 cell line. Diabetes. 45:37-43.
24. Sobey WJ, Beer SF, Carrington CA, et al. 1989 Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J. 260:535-541.
25. Van Schravendijk CHF, Kiekens R, Pipeleers DG. 1992 Pancreatic β cell heterogeneity in glucose-induced insulin secretion. J Biol Chem. 267:21344-21348.
26. Kiekens R, In't Veld P, Schuit F, Van De Winkel M, Pipeleers D. 1991 Differences in glucose recognition by individual rat pancreatic B cells are associated with intercellular differences in glucose-induced biosynthetic activity. J Clin Invest. 89:117-125.
27. Alarcon C, Leahy JL, Schuppin GT, Rhodes CJ. 1995 Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus. J Clin Invest. 95:1032-1039.
28. Hales CN. 1994 The pathogenesis of NIDDM. Diabetologia 37(Suppl 2):S162-S168.